RISEDRONIC ACID Pharmacologic Class Indexing
- Class set ID
- a465f189-1821-448d-9edd-a502aca5f0f3
- Version
- 2
- Effective date
- 20180813
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
Label, Manufacturer, Effective table| Label | Manufacturer | Effective | SPL version |
|---|
| These highlights do not include all the information needed to use RISEDRONATE SODIUM TABLETS safely and effectively. See full prescribing information for RISEDRONATE SODIUM TABLETS . RISEDRONATE SODIUM tablets, for oral use Initial U.S. Approval: 1998 | Teva Pharmaceuticals USA, Inc. | 20260330 | 15 |
| These highlights do not include all the information needed to use RISEDRONATE SODIUM TABLETS, USP safely and effectively. See Full Prescribing Information for RISEDRONATE SODIUM TABLETS, USP. RISEDRONATE SODIUM tablets, for oral use Initial U.S. Approval: 1998 | Apotex Corp. | Apotex Inc. | 20260302 | 15 |
| These highlights do not include all the information needed to use RISEDRONATE SODIUM TABLETS safely and effectively. See Full Prescribing Information for RISEDRONATE SODIUM TABLETS. RISEDRONATE SODIUM tablets, USP, for oral use Initial U.S. Approval: 1998 | Macleods Pharmaceuticals Limited | 20260301 | 9 |
| These highlights do not include all the information needed to use RISEDRONATE SODIUM TABLETS safely and effectively. See Full Prescribing Information for RISEDRONATE SODIUM TABLETS. RISEDRONATE SODIUM tablets, for oral use Initial U.S. Approval: 1998 | Sun Pharmaceutical Industries, Inc. | Sun Pharmaceutical Industries Limited | 20260217 | 17 |
| These highlights do not include all the information needed to use Risedronate Sodium safely and effectively. See full prescribing information for Risedronate Sodium . Risedronate Sodium tablets , for oral use Initial U.S. Approval: 1998 | Mylan Pharmaceuticals, Inc. | 20260212 | 13 |
| These highlights do not include all the information needed to use RISEDRONATE SODIUM TABLETS safely and effectively. See Full Prescribing Information for RISEDRONATE SODIUM TABLETS. RISEDRONATE SODIUM tablets, for oral use Initial U.S. Approval: 1998 | Aurobindo Pharma Limited | 20260211 | 9 |
| These highlights do not include all the information needed to use RISEDRONATE SODIUM TABLETS safely and effectively. See Full Prescribing Information for RISEDRONATE SODIUM TABLETS. RISEDRONATE SODIUM tablets, for oral use Initial U.S. Approval: 1998 | Aurobindo Pharma Limited | 20260210 | 8 |
| These highlights do not include all the information needed to use ACTONEL safely and effectively. See full prescribing information for ACTONEL. ACTONEL ® ( risedronate sodium ) tablets , for oral use Initial U.S. Approval: 199 8 | Allergan, Inc. | 20260204 | 31 |
| These highlights do not include all the information needed to use ATELVIA safely and effectively. See full prescribing information for ATELVIA . ATELVIA ® (risedronate sodium) delayed-release tablets Initial U.S. Approval: 1998 | Allergan, Inc. | 20260203 | 29 |
| These highlights do not include all the information needed to use RISEDRONATE SODIUM DELAYED-RELEASE safely and effectively. See full prescribing information for RISEDRONATE SODIUM DELAYED-RELEASE . RISEDRONATE SODIUM DELAYED-RELEASE tablets Initial U.S. Approval: 1998 | Mylan Pharmaceuticals, Inc. | 20260203 | 7 |
| These highlights do not include all the information needed to use RISEDRONATE SODIUM TABLETS safely and effectively. See Full Prescribing Information for RISEDRONATE SODIUM TABLETS. RISEDRONATE SODIUM tablets, for oral use Initial U.S. Approval: 1998 | Hangzhou Minsheng Binjiang Pharmaceutical CO., Ltd | 20251216 | 15 |
| These highlights do not include all the information needed to use RISEDRONATE SODIUM TABLETS, USP safely and effectively. See Full Prescribing Information for RISEDRONATE SODIUM TABLETS, USP. RISEDRONATE SODIUM tablets, for oral use Initial U.S. Approval: 1998 | Proficient Rx LP | 20221101 | 1 |
| These highlights do not include all the information needed to use RISEDRONATE SODIUM DELAYED-RELEASE TABLETS safely and effectively. See Full Prescribing Information for RISEDRONATE SODIUM DELAYED-RELEASE TABLETS. RISEDRONATE SODIUM delayed-release tablets, for oral use Initial U.S. Approval: 1998 | Sun Pharmaceutical Industires Inc. | Sun Pharmaceutical Industires Limited | 20200909 | 4 |
| These highlights do not include all the information needed to use RISEDRONATE SODIUM delayed-release tablets safely and effectively. See full prescribing information for RISEDRONATE SODIUM delayed-release tablets.RISEDRONATE SODIUM delayed-release tablets for oral use.Initial U.S. Approval: 1998 | Impax Generics | 20170430 | 9 |
| These highlights do not include all the information needed to use ACTONEL safely and effectively. See full prescribing information for ACTONEL. ACTONEL ® (risedronate sodium) tablets Initial U.S. Approval: 1998 | Physicians Total Care, Inc. | 20100324 | 2 |